Home > Share Market > Stocks > Natco pharma > Financial Statements> NATCOPHARM Profit & Loss

Natco Pharma Ltd Financial Statements

Profit & Loss Statement of Natco Pharma Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 2,052 1,915 2,185 2,020
yoy growth (%) 7.16 (12) 8.15 93.80
Raw materials (511) (382) (411) (599)
As % of sales 24.90 19.90 18.80 29.70
Employee costs (415) (375) (326) (243)
As % of sales 20.20 19.60 14.90 12
Other costs (520) (576) (520) (495)
As % of sales 25.30 30.10 23.80 24.50
Operating profit 606 583 928 683
OPM 29.50 30.40 42.50 33.80
Depreciation (117) (100) (66) (54)
Interest expense (13) (22) (15) (19)
Other income 104 107 40.40 13.90
Profit before tax 580 569 887 624
Taxes (137) (111) (192) (140)
Tax rate (24) (19) (22) (22)
Minorities and other (1.50) 2.70 1 1.10
Adj. profit 441 461 696 486
Exceptional items -- -- -- --
Net profit 441 461 696 486
yoy growth (%) (4.30) (34) 43.30 209
NPM 21.50 24.10 31.90 24.10

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000